ProShare Advisors’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-25,623
| Closed | -$29K | – | 2219 |
|
|
2022
Q1 | $29K | Sell |
25,623
-6,038
| -19% | -$6.83K | ﹤0.01% | 2156 |
|
|
2021
Q4 | $71K | Buy |
31,661
+20,445
| +182% | +$45.8K | ﹤0.01% | 2241 |
|
|
2021
Q3 | $38K | Sell |
11,216
-11,492
| -51% | -$38.9K | ﹤0.01% | 1980 |
|
|
2021
Q2 | $68K | Buy |
+22,708
| New | +$68K | ﹤0.01% | 2339 |
|
|
2016
Q4 | – | Sell |
-36,117
| Closed | -$56K | – | 1757 |
|
|
2016
Q3 | $56K | Sell |
36,117
-6,698
| -16% | -$10.4K | ﹤0.01% | 1438 |
|
|
2016
Q2 | $57K | Buy |
42,815
+294
| +0.7% | +$391 | ﹤0.01% | 1548 |
|
|
2016
Q1 | $224K | Sell |
42,521
-4,207
| -9% | -$22.2K | ﹤0.01% | 1359 |
|
|
2015
Q4 | $367K | Buy |
46,728
+4,534
| +11% | +$35.6K | ﹤0.01% | 1190 |
|
|
2015
Q3 | $357K | Sell |
42,194
-3,180
| -7% | -$26.9K | 0.01% | 1068 |
|
|
2015
Q2 | $497K | Sell |
45,374
-3,420
| -7% | -$37.5K | 0.01% | 1094 |
|
|
2015
Q1 | $682K | Buy |
48,794
+6,076
| +14% | +$84.9K | 0.01% | 1035 |
|
|
2014
Q4 | $722K | Sell |
42,718
-1,605
| -4% | -$27.1K | 0.01% | 1022 |
|
|
2014
Q3 | $595K | Sell |
44,323
-8,803
| -17% | -$118K | 0.01% | 1298 |
|
|
2014
Q2 | $677K | Sell |
53,126
-32,321
| -38% | -$412K | 0.01% | 1385 |
|
|
2014
Q1 | $1.02M | Buy |
85,447
+60,775
| +246% | +$723K | 0.01% | 1298 |
|
|
2013
Q4 | $341K | Sell |
24,672
-22,424
| -48% | -$310K | 0.01% | 1120 |
|
|
2013
Q3 | $822K | Buy |
47,096
+18,556
| +65% | +$324K | 0.02% | 1031 |
|
|
2013
Q2 | $464K | Buy |
+28,540
| New | +$464K | 0.01% | 1393 |
|